Heart® Intellectual Property
HEARTBRAN® - U.S. Patent 'Fortified Rice Bran Food Product and Method for
Promoting Cardiovascular Health' - issued August 20, 2002
Australia Patent - issued June 21, 2007
Singapore Patent - issued February 28, 2006
Japanese Patent - issued April 24, 2009
Mexico Patent - issued November 5, 2007
Canadian Patent -
issued July 17, 2012
Germany Patent - issued April 5, 2006
Spain Patent - issued April 5, 2006
France Patent - issued April 5, 2006
United Kingdom Patent - issued April 5, 2006
Ireland Patent -
issued April 5, 2006
Israel Patent - issued October 6, 2006
GUTBRAN® - US Patent 'Fortified Cereal Bran to Promote Digestive Health'
- issued April 20, 2010
Australia Patent - issued January 10, 2013
Canada - issued November 12, 2013
- issued March 30, 2011
Germany Patent - issued November 2, 2011
Spain Patent - issued November 2, 2011
France Patent - issued November
United Kingdom Patent - issued November 2, 2011
Ireland Patent - issued November 2, 2011
Light Heart LLC has completed a double-blind, placebo controlled
clinical study of Heartbran in chocolate bars at Pennington Biomedical Center In Baton Rouge, Louisiana.
A poster presentation
of the study was presented by Katie Caruso of the LSU Human Ecology department at the Experimental Biology Meeting in San
Diego on Monday, April 4, 2005 from 1:45 - 2:45PM. The abstract follows:
A Rice Bran Bar Containing Omega-3 Fatty Acids
and Vitamins Reduces Serum Homocysteine.
Caruso MK*, Greenway FL**, Hoffpauer DW***. *LSU
Human Ecology, **Pennington Center LSU System, ***Light Heart LLC.
A chocolate covered snack
bar containing 14 grams of full fat rice bran, 6.25 mg thiamine, 125 mg ascorbic acid, 6.25 mg pyridoxine, 37.5 mcg cyanocobalamin,
50 units tocopherol, 0.125 mg folic acid, 500 mg of omega-3 fatty acids and 220 calories was compared to a placebo bar without
vitamins, similar calories and corn starch/corn oil instead of rice bran/omega-3 fatty acids. Nine of 10 healthy subjects
on no regular medications, 25-45 yr. (men), 25-55 yr. (women), LDL 130-190 mg/dl and triglycerides 150-300 mg/dl completed
the randomized double-blind crossover trial with balanced order treatments. Subjects incorporated 6 bars/d in a weight maintaining
diet. Homocysteine and lipids were drawn twice at the end of each 4-week treatment period and compared by paired t-test.
Homocysteine decreased more during the rice bran bar period than during the placebo period (7.1 vs. 7.8 mcmol/L, p=0.028).
Total cholesterol, LDL, triglycerides and c-reactive protein decreased more and HDL increased more during the rice bran bar
period, but the changes were statistically insignificant. This bar for cardiovascular health decreased serum homocysteine,
a recognized cardiovascular risk factor.